Clinical Trial Update: Evaluation of the AMICUS RBCx System in Sickle Cell Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating the AMICUS RBCx System in sickle cell anemia with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• AMICUS RBCx System

Snippet

Sponsor: Fenwal, Inc. | Conditions: Sickle Cell Anemia | NA | Status: COMPLETED | Results posted: 2022-07-29